KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis
Europe - AMS:PHIA - NL0000009538 - Common Stock
24 EUR
-0.04 (-0.17%)
We assign a fundamental rating of 3 out of 10 to PHIA. PHIA was compared to 59 industry peers in the Health Care Equipment & Supplies industry. PHIA has a bad profitability rating. Also its financial health evaluation is rather negative. PHIA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year PHIA was profitable.
In the past year PHIA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
PHIA has a worse Return On Assets (0.61%) than 61.02% of its industry peers.
Looking at the Return On Equity, with a value of 1.56%, PHIA is doing worse than 61.02% of the companies in the same industry.
PHIA has a Return On Invested Capital (4.27%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4.27% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 0.91%, PHIA is doing worse than 62.71% of the companies in the same industry.
PHIA has a Operating Margin (6.11%) which is in line with its industry peers.
PHIA's Operating Margin has declined in the last couple of years.
PHIA's Gross Margin of 43.85% is on the low side compared to the rest of the industry. PHIA is outperformed by 69.49% of its industry peers.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
PHIA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PHIA has less shares outstanding
PHIA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PHIA is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.93 indicates that PHIA is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.93, PHIA is in line with its industry, outperforming 45.76% of the companies in the same industry.
PHIA has a debt to FCF ratio of 19.41. This is a negative value and a sign of low solvency as PHIA would need 19.41 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 19.41, PHIA is in line with its industry, outperforming 44.07% of the companies in the same industry.
PHIA has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
PHIA's Debt to Equity ratio of 0.69 is on the low side compared to the rest of the industry. PHIA is outperformed by 72.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.93 |
ROIC/WACC0.68
WACC6.27%
2.3 Liquidity
PHIA has a Current Ratio of 1.26. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
PHIA's Current ratio of 1.26 is on the low side compared to the rest of the industry. PHIA is outperformed by 69.49% of its industry peers.
PHIA has a Quick Ratio of 1.26. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of PHIA (0.81) is worse than 66.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
PHIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.17%, which is quite good.
PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.17% yearly.
PHIA shows a decrease in Revenue. In the last year, the revenue decreased by -1.53%.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)11.17%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%21.91%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-2.12%
3.2 Future
The Earnings Per Share is expected to grow by 12.35% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.00% on average over the next years.
EPS Next Y1.18%
EPS Next 2Y6.04%
EPS Next 3Y8.31%
EPS Next 5Y12.35%
Revenue Next Year-1.66%
Revenue Next 2Y0.97%
Revenue Next 3Y2.19%
Revenue Next 5Y3%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 16.67, PHIA is valued correctly.
Based on the Price/Earnings ratio, PHIA is valued cheaper than 88.14% of the companies in the same industry.
PHIA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.27.
PHIA is valuated correctly with a Price/Forward Earnings ratio of 15.41.
Based on the Price/Forward Earnings ratio, PHIA is valued a bit cheaper than 77.97% of the companies in the same industry.
PHIA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.67 | ||
| Fwd PE | 15.41 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHIA is valued a bit cheaper than the industry average as 77.97% of the companies are valued more expensively.
PHIA's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.25 | ||
| EV/EBITDA | 12.47 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)14.08
PEG (5Y)N/A
EPS Next 2Y6.04%
EPS Next 3Y8.31%
5. Dividend
5.1 Amount
PHIA has a Yearly Dividend Yield of 3.05%.
Compared to an average industry Dividend Yield of 2.30, PHIA pays a better dividend. On top of this PHIA pays more dividend than 89.83% of the companies listed in the same industry.
PHIA's Dividend Yield is a higher than the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.05% |
5.2 History
The dividend of PHIA decreases each year by -70.49%.
Dividend Growth(5Y)-70.49%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
PHIA pays out 0.62% of its income as dividend. This is a sustainable payout ratio.
DP0.62%
EPS Next 2Y6.04%
EPS Next 3Y8.31%
AMS:PHIA (9/15/2025, 5:36:15 PM)
24
-0.04 (-0.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners42.8%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.11B
Analysts75.38
Price Target27.41 (14.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.05% |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)1.11%
PT rev (3m)0.84%
EPS NQ rev (1m)1.27%
EPS NQ rev (3m)-12.9%
EPS NY rev (1m)-7.96%
EPS NY rev (3m)-7.96%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-5.99%
Revenue NY rev (1m)-0.91%
Revenue NY rev (3m)-2.78%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.67 | ||
| Fwd PE | 15.41 | ||
| P/S | 1.29 | ||
| P/FCF | 53.25 | ||
| P/OCF | 21.03 | ||
| P/B | 2.23 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.47 |
EPS(TTM)1.44
EY6%
EPS(NY)1.56
Fwd EY6.49%
FCF(TTM)0.45
FCFY1.88%
OCF(TTM)1.14
OCFY4.76%
SpS18.54
BVpS10.78
TBVpS-1.76
PEG (NY)14.08
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4.27% | ||
| ROICexc | 4.72% | ||
| ROICexgc | 15.5% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y10.6%
ROICexcg growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.93 |
F-Score8
WACC6.27%
ROIC/WACC0.68
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.17%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%21.91%
EPS Next Y1.18%
EPS Next 2Y6.04%
EPS Next 3Y8.31%
EPS Next 5Y12.35%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-2.12%
Revenue Next Year-1.66%
Revenue Next 2Y0.97%
Revenue Next 3Y2.19%
Revenue Next 5Y3%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year50.08%
EBIT Next 3Y20.59%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%